Please login to the form below
complementary therapies
This page shows the latest complementary therapies news and features for those working in and with pharma, biotech and healthcare.
Takeda agrees $5.2bn deal to buy Ariad
Opportunities to acquire such high-quality, complementary targeted therapies do not come often, and we are very excited about the potential for this transaction to benefit patients, our shareholders, and other
Latest news
-
UCB launches arthritis exercise programme in the UK
However, the move comes just as Arthritis Research UK publish a report that criticises many complementary therapies for arthritis as lacking scientific evidence of efficacy. ... Rheumatoid arthritis was singled out in the report as being an area where
-
R&D news in brief
Last month, a report written by economist Christopher Smallwood and commissioned by the Prince of Wales said that complementary therapies, including herbal medicines, should be used more frequently by the NHS.
-
Doctors attack NHS support of complementary medicine
It criticised two initiatives - a government-funded guide on homeopathy for patients, and the Smallwood Report, which was commissioned by Prince Charles, and advocates greater access to complementary therapies. ... She said: ìPatients rightly expect to
-
New laws for alternative medicines in UK
The UK government will regulate aromatherapy, homoeopathy and other complementary therapies in a scheme due later in 2008. ... The NHS spends GBP 50m a year on complementary therapies, which will be covered by the new council.
More from news
Approximately 1 fully matching, plus 4 partially matching documents found.
Latest Intelligence
-
Where next in Alzheimer’s disease R&D?
disease. Targeting tau. Tau is among the beneficiaries of the broader focus and emerging interest in combination therapies. ... These mechanisms may be complementary. “We think combination therapies between. antibodies and small molecules make a lot of
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Freelance Medical Writer - Creative Healthcare Comms - 2 month t...
-
Excellent Day Rate
- Client Services Director – London or Home Based – Medical Commun...
-
Highly Competitive Salary, Bonus &Benefits
-
Account Management
-
Competitive Salary Offered
- Freelance Account Manager - Creative Healthcare Comms - Immediat...
-
Excellent Day Rate
- Medical Writer, Senior Medical Writer, Principal Medical Writer,...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Content Editor - Biotechnology
-
Salary TBC
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Senior Leadership Role – Medical Communications – North West
-
Highly Competitive Salary, Bonus &Benefits
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
- AZ showcases data for next-generation PARP inhibitor AZD5305
- Sanofi pays $160m upfront to acquire Tidal Therapeutics
- GSK discontinues two feladilimab trials in head and neck cancer
- Novavax seeks FDA emergency approval for COVID-19 vaccine by May
- Pfizer/BioNTech say their COVID-19 vaccine can be stored at warmer temperatures
- Virtual congresses: video thrilled the cardio tsar
- Lilly asks to revoke emergency authorisation for bamlanivimab monotherapy in the US
- CureVac outlines COVID-19 vaccine production plans ahead of regulatory approval
- Alexion and NICE agree confidential discount for Ultomiris use on the NHS
- Novartis’ MS therapy Kesimpta reduces risk of disability progression regardless of relapses
- Merck & Co halts development of potential COVID-19 drug MK-7110
- Virtually, the same: Is it time to rethink congress strategy?
PMHub
Oxford University Press
Oxford University Press publishes over 100 prestigious, highly cited, and authoritative medical journals, many in collaboration with some of the...
Latest intelligence
- InSite Events™ National Pharma Meeting: A Customer Story
- How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
- Fear or encouragement, which is best to drive behaviour change?
- The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
- The unheard, unseen, and uncorrected effects of COVID-19
- The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...
Quick links
Infographics
